A SMART Design for Attendance-based Prize CM
Substance Abuse
About this trial
This is an interventional treatment trial for Substance Abuse focused on measuring Substance Abuse, Contingency Management
Eligibility Criteria
Inclusion Criteria:
- age > 18 years
- current DSM-IV diagnosis of cocaine abuse or dependence or recent cocaine use (self-reported use in past 30 days or positive urine toxicology screen)
- willing to sign informed consent and able to pass an informed consent quiz
Exclusion Criteria:
- serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
- in recovery from pathological gambling (meet DSM-IV criteria for lifetime pathological gambling and are actively trying to refrain from gambling)
- do not speak English (all treatment is provided in English at these clinics)
Sites / Locations
- University of Connecticut Health Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
No Intervention
Experimental
No Intervention
Experimental
Treatment Group A
Treatment Group B
Aftercare Group A
Aftercare Group B
Individuals randomized to Treatment Group A will receive standard treatment for study weeks 1-6.
Individuals randomized to Treatment Group B will receive contingency management plus standard treatment for study weeks 1-6.
All participants will be re-randomized after study week 6. Those participants assigned to Aftercare Group A will receive standard treatment for study weeks 7-12.
All participants will be re-randomized after study week 6. Those participants assigned to Aftercare Group B will receive contingency management treatment plus standard treatment for weeks 7-12.